Implementation of a liver health check in people with type 2 diabetes
Source
Lancet gastroenterology & hepatology - ISSN 2468-1253-9:1 (2024) p. 83-91
Efficacy and safety of elafibranor in primary biliary cholangitis
Source
The New England journal of medicine - ISSN 0028-4793-390 (2024) p. 795-805
Learnings from the graveyard of phase 2 and 3 nonalcoholic steatohepatitis trials
Source
Clinical gastroenterology and hepatology - ISSN 1542-3565-22:1 (2024) p. 16-19
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis
Source
Hepatology Communications - ISSN 2471-254X-8:2 (2024) p. 1-8
Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)
Source
Frontiers in molecular medicine - ISSN 2674-0095-3 (2024) p. 1-19